Blog
RSS FeedPosted by Michael Wonder on 22 Sep 2016
CADTH calls for patient input on a resubmission from NovoNordisk for Victoza (liraglutide)
21 September 2016 - CADTH is calling for patient input on a resubmission from Novo Nordisk for Victoza (liraglutide). ...
Posted by Michael Wonder on 30 Aug 2016
CADTH recommends the reimbursement of Invokamet (canagliflozin hemihydrate with metformin hydrochloride)
25 August 2016 - CADTH has published its final recommendation on the reimbursement of Invokamet in Canada. ...
Posted by Michael Wonder on 11 Aug 2016
CADTH provides an update on its therapeutic review of new drugs for type 2 diabetes mellitus
10 August 2016 - CADTH is undertaking a project to assess the clinical and cost-effectiveness of new drugs for the treatment ...
Posted by Michael Wonder on 30 Mar 2016
Call for patient input on a submission from Boehringer Ingelheim for Jardiance (empagliflozin)
30 March 2016 - CADTH has received notice of a pending submission from Boehringer Ingelheim for empagliflizin (Jardiance) for use by ...
Posted by Michael Wonder on 23 Feb 2016
Call for feedback: new drugs for type 2 diabetes: a therapeutic review update
22 February 2016 - A proposed CADTH project scope on new drugs for type 2 diabetes mellitus: a therapeutic review update ...
Posted by Michael Wonder on 03 Feb 2016
CADTH calls for patient input on a new submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride
3 February 2016 - CADTH has received notice of a pending submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride for ...
Posted by Michael Wonder on 01 Dec 2015
CADTH calls for patient input on a new submission from AstraZeneca for Xigduo
1 December 2015 - CADTH has received notice of a pending submission from AstraZeneca for Xigduo (dapagliflozin propanediol monohydrate with metformin ...
Posted by Michael Wonder on 17 Nov 2015
CADTH calls for patient input on a new submission from Eli Lilly for Trulicity
17 November 2015 - CADTH has received notice of a pending submission from Eli LIlly for dulaglutide (Trulicity) for use by ...
Posted by Michael Wonder on 22 Oct 2015
Jardiance (empagliflozin) recommended by CADTH for use in combination with metformin hydrochloride and a sulphonylurea
15 October 2015 - The CADTH Canadian Drug Expert Committee has recommended that empagliflozin be listed for the treatment of ...